Trichome Financial Corp. Completes Plan of Arrangement with IM Cannabis Corp.

TORONTO, ON / ACCESSWIRE / March 18, 2021 / Trichome Financial Corp. (the “Company” or “Trichome Financial”) (CSE:TFC) is pleased to announce the closing of its previously announced combination with IM Cannabis Corp (NASDAQ:IMCC) (CSE:IMCC)(“IMC”), having received a final order from the Ontario Superior Court of Justice, Commercial List approving the transaction pursuant to which IM Cannabis Corp. agreed to acquire all of the issued and outstanding common shares of Trichome Financial by way of a plan of arrangement (the “Arrangement”).

The shares of Trichome Financial will be delisted from the Canadian Securities Exchange effective immediately. Shareholders of Trichome Financial will receive 0.24525 common shares of IMC for each common share of Trichome Financial. IMC common shares trade on the NASDAQ Capital Market and the Canadian Securities Exchange under the ticker “IMCC”.

About IM Cannabis Corp.

IMC is a multi-country operator in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry.

In Europe, IMC operates through Adjupharm GmbH, a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC’s European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.

About Trichome Financial Corp.

Trichome Financial is a specialty finance company focused on providing flexible and creative capital solutions to the global legal cannabis market. Trichome was created to address the lack of credit availability in the large, growing and increasingly complex cannabis market. Trichome Financial’s experienced founders and management team have a unique edge to capitalize on proprietary deal flow and industry insight in order to drive the best risk-adjusted returns on shareholder’s capital. With the recent acquisition of the assets of James E. Wagner Cultivation Corp., Trichome Financial is focused on acquiring related assets to compliment JWC and leverage the knowledge, expertise and insights of its employees, management and founders.

For further information about Trichome please visit us at or @trichomefinance on Twitter and refer to the joint information circular of Trichome and 22 Capital dated May 29, 2019 which is available on the Trichome’s SEDAR profile at

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter